Advances in targeting 'undruggable'transcription factors with small molecules

MJ Henley, AN Koehler - Nature Reviews Drug Discovery, 2021 - nature.com
Transcription factors (TFs) represent key biological players in diseases including cancer,
autoimmunity, diabetes and cardiovascular disease. However, outside nuclear receptors …
被引用次数：103 相关文章

Advances in targeting'undruggable'transcription factors with small molecules.

MJ Henley, AN Koehler - Nature reviews. Drug Discovery, 2021 - europepmc.org
Transcription factors (TFs) represent key biological players in diseases including cancer,
autoimmunity, diabetes and cardiovascular disease. However, outside nuclear receptors …
[PDF] cellestia.com

[PDF][PDF] Advances in targeting 'undruggable'transcription factors with small molecules

MJ Henley, AN Koehler - Nature reviews| Drug Discovery - cellestia.com
Transcription factors (TFs) represent key biological players in diseases including cancer,
autoimmunity, diabetes and cardiovascular disease. However, outside nuclear receptors …

Advances in targeting'undruggable'transcription factors with small molecules.

MJ Henley, AN Koehler - Nature Reviews Drug Discovery, 2021 - go.gale.com
Transcription factors (TFs) represent key biological players in diseases including cancer,
autoimmunity, diabetes and cardiovascular disease. However, outside nuclear receptors …

Advances in targeting'undruggable'transcription factors with small molecules

MJ Henley, AN Koehler - Nature reviews. Drug discovery, 2021 - pubmed.ncbi.nlm.nih.gov
Transcription factors (TFs) represent key biological players in diseases including cancer,
autoimmunity, diabetes and cardiovascular disease. However, outside nuclear receptors …